Stock ETON ETON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
3.29 USD -0.90% Intraday chart for Eton Pharmaceuticals, Inc. -1.50% -24.89%
05-09 Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09 Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HC Wainwright Adjusts Eton Pharmaceuticals Price Target to $10 From $9, Maintains Buy Rating
MT
HC Wainwright Trims Price Target on Eton Pharmaceuticals to $9 From $10, Maintains Buy Rating
MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $10 From $9, Keeps Buy Rating
MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $9 from $11, Keeps Buy Rating
MT
B. Riley Trims Eton Pharmaceuticals' Price Target to $9 from $10 But Notes 'Solid' Growth Prospects Despite Partner Setback, Keeps Buy Rating
MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $11 From $14, Keeps Buy Rating
MT
ETON PHARMACEUTICALS : B. Riley Resumes Eton Pharmaceuticals at Buy with $10 PT, Sees Potential in 'Robust' Pipeline Despite Regulatory Challenges, Related Delays
MT
ETON PHARMACEUTICALS : B. Riley Lowers Eton Pharmaceuticals' PT to $11 from $13 on Lowered Probability of Success for DS100, Keeps Buy Rating
MT
ETON PHARMACEUTICALS : HC Wainwright Adjusts Eton Pharmaceuticals's Price Target to $15 From $20, Keeps at Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ETON Stock
  4. News Eton Pharmaceuticals, Inc.
  5. Analyst Reco.